VanEck Biotech ETF
Van Eck Associates Corp. BBH ETF
| BBH Price | $180.65 |
Market Cap | $461.92M |
| Annual Dividend Yield | 0.39% |
Annual Dividend | $0.71 |
| Yearly Management Fee | 0.35% |
Asset Class | Equity |
| Focus | Health care |
Category | Sector, Health Care |
| Niche | Biotechnology |
Last 24h Volume | $4.43K |
| Portfolio Management Company | Van Eck Associates Corp. |
Discount/Premium to NAV | 0.00% |
| Inception Date | Dec 20, 2011 |
Market Cap Rank | 1049 |
| Monthly AUM Growth | 1.12% |
Holdings Region | Global |
| Management Style | Passive |
Leverage | Non-Leveraged |
VanEck Biotech ETF is an ETF issued by Van Eck Associates Corp. on Dec 20 2011.
The main focus of this ETF, which is in the "Equity" asset class, is determined as "Health care".
As of today, the price of BBH ETF according to its net asset value is premiumed at 0.00%.
While the total value of the fund shows $5.14M increase compared to the previous month, its price is traded daily at a decrease of -0.12%.
The annual dividend yield of BBH ETF is 0.39%, whereas its main asset area is Global.
BBH ETF, whose 24-hour total volume is $4.43K, has experienced a $0 cash outflow in the last month.
In addition, VanEck Biotech ETF's one-year net asset value total return is 13.48%.
BBH ETF Returns
| Daily |
Weekly |
Monthly |
3 Mo |
6 Mo |
YTD |
Yearly |
| -0.12% |
2.67% |
0.54% |
9.60% |
8.88% |
9.80% |
13.72% |
BBH ETF NAV Total Return
| Monthly |
3 Mo |
YTD |
Yearly |
3 Years |
5 Years |
| -0.99% |
8.38% |
9.22% |
13.48% |
-14.62% |
49.94% |
BBH ETF Comments
no comments yet